Unknown

Dataset Information

0

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer.


ABSTRACT: Esophageal squamous precancerous lesions (ESPL) are the precursors of esophageal squamous cell carcinoma (ESCC) including low-grade and high-grade intraepithelial neoplasia. Due to the absence of molecular indicators, which ESPL will eventually develop into ESCC and thus should be treated is not well defined. Indicators, for predicting risks of ESCC at ESPL stages, are an urgent need. We perform spatial whole-transcriptome atlas analysis, which can eliminate other tissue interference by sequencing the specific ESPL regions. In this study, the expression of TAGLN2 significantly increases, while CRNN expression level decreases along the progression of ESCC. Additionally, TAGLN2 protein level significantly increases in paired after-progression tissues compared with before-progression samples, while CRNN expression decreases. Functional studies suggest that TAGLN2 promotes ESCC progression, while CRNN inhibits it by regulating cell proliferation. Taken together, TAGLN2 and CRNN are suggested as candidate indicators for the risk of ESCC at ESPL stages.

SUBMITTER: Liu X 

PROVIDER: S-EPMC10409784 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer.

Liu Xuejiao X   Zhao Simin S   Wang Keke K   Zhou Liting L   Jiang Ming M   Gao Yunfeng Y   Yang Ran R   Yan Shiwen S   Zhang Wen W   Lu Bingbing B   Liu Feifei F   Zhao Ran R   Liu Wenting W   Zhang Zihan Z   Liu Kangdong K   Li Xiang X   Dong Zigang Z  

Nature communications 20230808 1


Esophageal squamous precancerous lesions (ESPL) are the precursors of esophageal squamous cell carcinoma (ESCC) including low-grade and high-grade intraepithelial neoplasia. Due to the absence of molecular indicators, which ESPL will eventually develop into ESCC and thus should be treated is not well defined. Indicators, for predicting risks of ESCC at ESPL stages, are an urgent need. We perform spatial whole-transcriptome atlas analysis, which can eliminate other tissue interference by sequenci  ...[more]

Similar Datasets

| S-EPMC10537352 | biostudies-literature
| S-EPMC8479167 | biostudies-literature
| S-EPMC8919643 | biostudies-literature
| S-EPMC9613556 | biostudies-literature
| S-EPMC10011538 | biostudies-literature
2025-05-07 | PXD054190 | Pride
| S-EPMC9276202 | biostudies-literature
| S-EPMC11799171 | biostudies-literature
2017-08-30 | GSE103254 | GEO
| S-EPMC11808962 | biostudies-literature